0001127602-15-022972.txt : 20150716
0001127602-15-022972.hdr.sgml : 20150716
20150716170834
ACCESSION NUMBER: 0001127602-15-022972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150715
FILED AS OF DATE: 20150716
DATE AS OF CHANGE: 20150716
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haluska Frank
CENTRAL INDEX KEY: 0001494892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36172
FILM NUMBER: 15992023
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-07-15
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001494892
Haluska Frank
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
SVP, Clinical R&D, CMO
Common Stock
2015-07-15
4
M
0
8000
0
A
122124
D
Common Stock
2015-07-16
4
S
0
4400
8.5397
D
117724
D
Performance stock unit
2015-07-15
4
M
0
8000
0
D
Common Stock
8000
0
D
Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
Each performance stock unit represents a right to receive one share of ARIAD common stock.
The performance stock units vested on 7/15/15.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2015-07-16